- Investing Ideas
- Argentinian Pharmaceuticals & Biotech Potentially Undervalued Companies
Argentinian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
19
Companies with a Value score of at least 3, ordered by Value score
19 companies
Gilead Sciences
Market Cap: AR$165.0b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
AR$53,725.00
7D
1.2%
1Y
35.5%
Bristol-Myers Squibb
Market Cap: AR$132.4b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY
AR$33,620.00
7D
-3.1%
1Y
64.2%
Amgen
Market Cap: US$225.6b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGND
US$14.24
7D
7.5%
1Y
47.0%
Bristol-Myers Squibb
Market Cap: US$129.9b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMYD
US$22.85
7D
5.0%
1Y
49.8%
Bayer
Market Cap: AR$22.5b
Operates as a life science company worldwide.
BAYN
AR$3,323.26
7D
0%
1Y
n/a
Novo Nordisk
Market Cap: US$1.4t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NVOD
US$7.09
7D
7.4%
1Y
n/a
Amgen
Market Cap: AR$225.6b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
AR$21,800.00
7D
6.3%
1Y
73.0%
Novo Nordisk
Market Cap: AR$1.4t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NVO
AR$10,670.00
7D
6.5%
1Y
n/a
GSK
Market Cap: US$76.0b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSKD
US$13.49
7D
0.7%
1Y
46.8%
Gilead Sciences
Market Cap: US$165.0b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILDD
US$34.56
7D
-1.3%
1Y
13.9%
GSK
Market Cap: AR$76.0b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
AR$20,160.00
7D
-0.6%
1Y
59.4%
AstraZeneca
Market Cap: AR$183.7b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
AR$62,900.00
7D
2.4%
1Y
25.9%
Tempus AI
Market Cap: AR$9.9b
Operates as a healthcare technology company in the United States.
TEM
AR$7,335.00
7D
18.0%
1Y
0.3%
Vertex Pharmaceuticals
Market Cap: AR$132.8b
Operates as a biotechnology company in the United States, Europe, and internationally.
VRTX
AR$8,275.00
7D
11.1%
1Y
62.9%
Vertex Pharmaceuticals
Market Cap: US$132.8b
Operates as a biotechnology company in the United States, Europe, and internationally.
VRTXD
US$5.51
7D
10.6%
1Y
43.3%
Novartis
Market Cap: US$239.2b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NVSD
US$40.02
7D
0.8%
1Y
29.9%
Novartis
Market Cap: AR$239.2b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NVS
AR$61,250.00
7D
1.2%
1Y
54.8%
Tempus AI
Market Cap: US$9.9b
Operates as a healthcare technology company in the United States.
TEMD
US$4.76
7D
16.8%
1Y
n/a
AstraZeneca
Market Cap: US$183.7b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZND
US$41.22
7D
1.8%
1Y
10.5%